- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Merck KGaA ADR (MKKGY)Merck KGaA ADR stock price live, this page displays OTC MKKGY stock exchange data. View the MKKGY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Merck KGaA ADR real time stock price chart below.
What Is the Merck KGaA ADR Stock Price Today?
The Merck KGaA ADR stock price today is 30.205.
What Is the Stock Symbol for Merck KGaA ADR?
The stock symbol for Merck KGaA ADR is "MKKGY."
What Stock Exchange Does Merck KGaA ADR Trade On?
Merck KGaA ADR is listed and trades on the OTC Markets stock exchange.
Is Merck KGaA ADR a Good Stock to Buy?
Determining whether Merck KGaA ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MKKGY quote. (ISIN: US5893392093)
What Is the Merck KGaA ADR Stock Price Today?
The Merck KGaA ADR stock price today is 30.205.
What Is the Stock Symbol for Merck KGaA ADR?
The stock symbol for Merck KGaA ADR is "MKKGY."
What Stock Exchange Does Merck KGaA ADR Trade On?
Merck KGaA ADR is listed and trades on the OTC Markets stock exchange.
Is Merck KGaA ADR a Good Stock to Buy?
Determining whether Merck KGaA ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MKKGY quote. (ISIN: US5893392093)
30.205
-0.110(-0.36%)
Closed
After Hours
30.260+0.055(+0.182%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.150
30.300
52 wk Range
28.964
39.170
MKKGY Scorecard
Full Analysis
Has raised its dividend for 4 consecutive years
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.15030.300
52 wk Range
28.96439.170
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.05%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.05%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MKKGY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Price Target
40.100
Upside
+32.759%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
- Merck Kgaa receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Merck Kgaa receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Merck Kgaa receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Merck Kgaa receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Merck Kgaa receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Merck Kgaa receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Merck ADR Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies. Its Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software. The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions. In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KGaA.
Compare MKKGY to Peers and Sector
Metrics to compare | MKKGY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMKKGYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 23.3x | 18.1x | −0.6x | |
PEG Ratio | −3.31 | 0.05 | 0.00 | |
Price/Book | 2.2x | 2.8x | 2.6x | |
Price / LTM Sales | 3.0x | 2.1x | 3.2x | |
Upside (Analyst Target) | 32.3% | 32.8% | 40.6% | |
Fair Value Upside | Unlock | 15.7% | 7.1% | Unlock |
Analysts' Recommendations
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 40.100
(+32.76% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.2
Dividend Yield
1.05%
Industry Median 1.73%
Annualised payout
0.3165
Paid annually
5-Years Growth
-
Growth Streak
FAQ
What Is the Merck ADR (MKKGY) Stock Price Today?
The Merck ADR stock price today is 30.205.
What Stock Exchange Does Merck ADR Trade On?
Merck ADR is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Merck ADR?
The stock symbol for Merck ADR is "MKKGY."
Does Merck ADR Pay Dividends? What’s The Current Dividend Yield?
The Merck ADR dividend yield is 1.05%.
What Is the Merck ADR Market Cap?
As of today, Merck ADR market cap is 65.80B.
What is Merck ADR Earnings Per Share?
The Merck ADR EPS is 6.20.
What Is the Next Merck ADR Earnings Date?
Merck ADR will release its next earnings report on 05 Mar 2025.
From a Technical Analysis Perspective, Is MKKGY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.